Physician

Vincenzo Galati, D.O.

According to 2025 Medicare claims, Vincenzo Galati, D.O. (NPI: 1376693754) practices urology in the Cape Girardeau, MO-IL market, with the plurality of this provider's patient population coming from Cape Girardeau, MO. This provider's primary affiliated billing organization is CAPE GIRARDEAU UROLOGY ASSOCIATES, INC. (NPI: 1194734582; TIN: 430984708) and primary practice location at 63703-4927. Galati is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Galati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 712 traditional Medicare patients, billed 10,530 HCPCS/CPT codes, and received $269,018 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,299 prescription claims across 415 beneficiaries totaling $115,291 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 101 claims. Open Payments data shows 40 records totaling $1,103. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,296 and ending at $1,050.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$226K$452K2015 Medicare payment: $249,631 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $322,415 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $417,260 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $449,431 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $451,838 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $375,313 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $404,412 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $329,584 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $302,509 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $269,018 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157004,924$249,631
20168867,448$322,415
20171,01611,299$417,260
20181,00113,479$449,431
201999315,006$451,838
20208858,243$375,313
20218889,023$404,412
202278310,244$329,584
20238159,902$302,509
202471210,530$269,018

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$194K$388K2015 Drug cost: $127,822 (USD; Tot_Drug_Cst)2016 Drug cost: $162,244 (USD; Tot_Drug_Cst)2017 Drug cost: $192,852 (USD; Tot_Drug_Cst)2018 Drug cost: $181,980 (USD; Tot_Drug_Cst)2019 Drug cost: $205,512 (USD; Tot_Drug_Cst)2020 Drug cost: $255,937 (USD; Tot_Drug_Cst)2021 Drug cost: $366,203 (USD; Tot_Drug_Cst)2022 Drug cost: $387,733 (USD; Tot_Drug_Cst)2023 Drug cost: $172,517 (USD; Tot_Drug_Cst)2024 Drug cost: $115,291 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154101,895$127,822
20164812,249$162,244
20175432,719$192,852
20185692,597$181,980
20195662,751$205,512
20205552,507$255,937
20215672,477$366,203
20225602,331$387,733
20234761,832$172,517
20244151,299$115,291

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$25K$49K2015 Medicare payment: $36,475 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $43,514 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $46,381 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $42,734 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $33,525 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $23,362 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $21,249 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $22,054 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $49,485 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $36,013 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201535191$36,475
201641257$43,514
201721209$46,381
201822198$42,734
201917180$33,525
202018141$23,362
202116101$21,249
20221788$22,054
202320137$49,485
202413101$36,013

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more287357$83
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's248295$11
36415Insertion of needle into vein for collection of blood sample226293$9
51798Ultrasound measurement of bladder capacity after voiding160194$7
81000Manual urinalysis test with examination using microscope, non-automated497698$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron923,095$46,492
GemtesaVibegron652,100$34,023
Methenamine HippurateMethenamine Hippurate662,100$3,724
Tamsulosin HclTamsulosin Hcl32617,322$3,190
Solifenacin SuccinateSolifenacin Succinate1032,957$2,968

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachN1364$18,419
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R23$17,240
A4332Lubricant, individual sterile packet, eachNN/R14$354

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$1,103Edap Technomed Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vincenzo Galati, D.O.?

Tedicare shows public-source Medicare data for Vincenzo Galati, D.O. (NPI 1376693754), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vincenzo Galati, D.O. have ACO affiliation data?

Vincenzo Galati, D.O. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Vincenzo Galati, D.O.?

Vincenzo Galati, D.O. is linked to CAPE GIRARDEAU UROLOGY ASSOCIATES, INC. (billing NPI 1194734582) in the available physician profile data.

Does Vincenzo Galati, D.O. have Open Payments data?

Vincenzo Galati, D.O. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.